Get the Stockscreener App
0.00
100.00%
-5.11
Eliem Therapeutics Inc Stock (ELYM) Forecast
The Eliem Therapeutics Inc (ELYM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.1236, representing a + increase from the current price of $0.00. The highest analyst price target is $2.6143, and the lowest is $1.6329.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ELYM Price Target
Average 2.2394
(+ Upside)
Is Eliem Therapeutics Inc (ELYM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 14.02 | Buy |
| STOCH(9,6) | 6.4509 | Buy |
| STOCHRSI(14) | 5.7697 | Buy |
| MACD(12,26) | -0.9809 | Sell |
| ADX(14) | 37.40 | Sell |
| William %R | -100.00 | Buy |
| CCI(14) | -260.47 | Sell |
Buy: 4
Sell: 3
Neutral: 0
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.346
Sell
|
4.8203
Sell
|
| MA20 |
6.6645
Sell
|
5.8356
Sell
|
| MA50 |
6.7994
Sell
|
6.5636
Sell
|
| MA100 |
7.274
Sell
|
6.5177
Sell
|
| MA200 |
5.3717
Sell
|
5.2457
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ELYM could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on ELYM, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 14.02 indicates that ELYM is oversold. This indicates that ELYM price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 6.4509 indicates that ELYM is oversold. This indicates that ELYM price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.7697 indicates that ELYM is oversold. This suggests that ELYM price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 37.4 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -260.47 indicates that ELYM is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ELYM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Eliem Therapeutics Inc financial reports and earnings history, Eliem Therapeutics Inc (ELYM) stock could reach $4.5329 by 2030, $4.2748 by 2040 and $9.0388 by 2050. See the projected annual prices until 2050 of the Eliem Therapeutics Inc stock below:
- Eliem Therapeutics Inc (ELYM) is expected to reach an average price of $2.1386 in 2035, with a high prediction of $4.25 and a low estimate of $1.3343. This indicates an $ rise from the last recorded price of $0.00.
- Eliem Therapeutics Inc (ELYM) stock is projected to chart a bullish course in 2040, with an average price target of $4.296, representing an $ surge from its current level. The forecast ranges from a conservative $4.3162 to a sky-high $4.2748.
- Our analysts predict Eliem Therapeutics Inc (ELYM) to jump by 2045, soaring from $6.8675 to an average price of $6.8246, potentially reaching $6.786. While $6.8675 is the low estimate, the potential upside is significant.
- Eliem Therapeutics Inc (ELYM) stock is expected to climb by 2050, reaching an average of $9.2888, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.0388 and $9.3532, respectively, highlighting the market's uncertainty.
Eliem Therapeutics Inc Stock (ELYM) Year by Year Forecast
Eliem Therapeutics Inc Stock (ELYM) Price Forecast for 2025
Eliem Therapeutics Inc Stock (ELYM) is expected to reach an average price of $2.2394 in 2025, with a high prediction of $3.5044 and a low estimate of $0.9744. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $2.0358 | $1.6329 | $2.6143 | + |
| April, 2025 | $1.4529 | $1.4029 | $2.2576 | + |
| May, 2025 | $1.2786 | $1.1287 | $1.6844 | + |
| June, 2025 | $3.3944 | $1.1101 | $3.5044 | + |
| July, 2025 | $2.1315 | $1.9016 | $3.4058 | + |
| August, 2025 | $2.3272 | $0.9744 | $2.7558 | + |
| September, 2025 | $1.983 | $1.3615 | $3.0187 | + |
| October, 2025 | $1.9201 | $1.5801 | $2.3487 | + |
| November, 2025 | $1.7858 | $1.4244 | $2.503 | + |
| December, 2025 | $1.133 | $1.133 | $1.8701 | + |
Eliem Therapeutics Inc Stock (ELYM) Price Forecast for 2026
The predicted value for Eliem Therapeutics Inc (ELYM) in 2026 is set at an average of $3.9252. Estimates vary from a peak of $6.6659 to a trough of $1.1844, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.5287 | $1.1958 | $1.9458 | + |
| February, 2026 | $1.4544 | $1.3801 | $1.7601 | + |
| March, 2026 | $1.4601 | $1.2873 | $1.5458 | + |
| April, 2026 | $1.4373 | $1.2873 | $1.6144 | + |
| May, 2026 | $1.453 | $1.3387 | $1.5401 | + |
| June, 2026 | $1.371 | $1.2444 | $1.5259 | + |
| July, 2026 | $1.4559 | $1.1844 | $1.7644 | + |
| August, 2026 | $1.7216 | $1.4673 | $1.8116 | + |
| September, 2026 | $1.4603 | $1.4044 | $1.823 | + |
| October, 2026 | $1.5845 | $1.4552 | $1.7445 | + |
| November, 2026 | $1.4602 | $1.3802 | $1.8102 | + |
| December, 2026 | $4.0637 | $1.4616 | $6.6659 | + |
Eliem Therapeutics Inc Stock (ELYM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Eliem Therapeutics Inc (ELYM) is $4.4379, with a high forecast of $8.8743 and a low forecast of $0.00158. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.3886 | $5.3157 | $8.24 | + |
| February, 2027 | $7.12 | $5.3572 | $7.8043 | + |
| March, 2027 | $6.4743 | $5.4215 | $8.8743 | + |
| April, 2027 | $5.6858 | $5.48 | $6.6372 | + |
| May, 2027 | $1.7972 | $0.00158 | $5.8386 | + |
| June, 2027 | $1.4215 | $0.0771 | $2.1215 | + |
| July, 2027 | $0.8429 | $0.3301 | $2.6144 | + |
| August, 2027 | $0.6144 | $0.2815 | $1.6215 | + |
| September, 2027 | $0.5087 | $0.0372 | $0.7808 | + |
| October, 2027 | $0.6014 | $0.2846 | $1.2701 | + |
| November, 2027 | $0.7715 | $0.3658 | $1.3487 | + |
| December, 2027 | $0.1958 | $0.1458 | $0.9948 | + |
Eliem Therapeutics Inc Stock (ELYM) Price Forecast for 2028
In 2028, Eliem Therapeutics Inc (ELYM) is projected to reach an average price of $1.1321, with a high projection of $2.2587 and a low estimate of $0.00557. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0273 | $0.00557 | $0.4287 | + |
| February, 2028 | $2.1487 | $0.034 | $2.2587 | + |
| March, 2028 | $0.893 | $0.6631 | $2.1616 | + |
| April, 2028 | $1.0945 | $0.0816 | $1.5216 | + |
| May, 2028 | $0.4488 | $0.133 | $1.7873 | + |
| June, 2028 | $0.7002 | $0.3602 | $1.1273 | + |
| July, 2028 | $0.5716 | $0.2088 | $1.2859 | + |
| August, 2028 | $0.0741 | $0.0741 | $0.6602 | + |
| September, 2028 | $0.3274 | $0.00834 | $0.7417 | + |
| October, 2028 | $0.2588 | $0.1802 | $0.5602 | + |
| November, 2028 | $0.2731 | $0.0945 | $0.3531 | + |
| December, 2028 | $0.2546 | $0.1046 | $0.4288 | + |
Eliem Therapeutics Inc Stock (ELYM) Price Forecast for 2029
The 2029 price forecast for Eliem Therapeutics Inc Stock (ELYM) is $3.7887 on average, with a high prediction of $7.5586 and a low estimate of $0.0189. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.2289 | $0.0689 | $0.3603 | + |
| February, 2029 | $0.2203 | $0.0503 | $0.4003 | + |
| March, 2029 | $0.2917 | $0.0189 | $0.5989 | + |
| April, 2029 | $0.5632 | $0.3046 | $0.6532 | + |
| May, 2029 | $0.3091 | $0.2489 | $0.666 | + |
| June, 2029 | $0.4389 | $0.3053 | $0.5989 | + |
| July, 2029 | $0.3203 | $0.2403 | $0.6703 | + |
| August, 2029 | $2.9275 | $0.3232 | $5.5318 | + |
| September, 2029 | $5.0629 | $3.9886 | $6.91 | + |
| October, 2029 | $5.0543 | $4.0357 | $6.4814 | + |
| November, 2029 | $5.1615 | $4.1072 | $7.5586 | + |
| December, 2029 | $4.3786 | $4.1701 | $5.3258 | + |
Eliem Therapeutics Inc Stock (ELYM) Price Forecast for 2030
Eliem Therapeutics Inc Stock (ELYM) is expected to reach an average price of $2.2706 in 2030, with a high forecast of $4.5329 and a low forecast of $0.00833. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.4699 | $0.5642 | $4.5329 | + |
| February, 2030 | $0.1272 | $0.3628 | $0.8272 | + |
| March, 2030 | $0.4456 | $0.2542 | $1.3215 | + |
| April, 2030 | $0.6684 | $0.547 | $0.3373 | + |
| May, 2030 | $0.767 | $0.9813 | $0.8356 | + |
| June, 2030 | $0.6685 | $0.7997 | $0.7227 | + |
| July, 2030 | $0.4684 | $0.5227 | $0.4513 | + |
| August, 2030 | $1.0612 | $0.6624 | $0.7412 | + |
| September, 2030 | $1.2241 | $1.0669 | $1.1368 | + |
| October, 2030 | $0.3324 | $0.1874 | $1.0131 | + |
| November, 2030 | $0.3455 | $0.00833 | $0.516 | + |
| December, 2030 | $0.1383 | $0.5083 | $0.6019 | + |
0.03%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):